These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7507646)

  • 1. Very low maternal serum chorionic gonadotropin levels in association with fetal triploidy.
    Schmidt D; Shaffer LG; McCaskill C; Rose E; Greenberg F
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):77-80. PubMed ID: 7507646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal serum screening for alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin between 11 and 15 weeks of pregnancy to detect fetal chromosome abnormalities.
    Crandall BF; Hanson FW; Keener S; Matsumoto M; Miller W
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1864-7; discussion 1867-9. PubMed ID: 7686337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, and unconjugated estriol levels in midtrimester trisomy 18 pregnancies.
    Greenberg F; Schmidt D; Darnule AT; Weyland BR; Rose E; Alpert E
    Am J Obstet Gynecol; 1992 May; 166(5):1388-92. PubMed ID: 1375811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
    Yaron Y; Cherry M; Kramer RL; O'Brien JE; Hallak M; Johnson MP; Evans MI
    Am J Obstet Gynecol; 1999 Oct; 181(4):968-74. PubMed ID: 10521763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
    Burton BK; Prins GS; Verp MS
    Am J Obstet Gynecol; 1993 Sep; 169(3):526-30. PubMed ID: 7690522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
    Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
    Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The advantages of using triple-marker screening for chromosomal abnormalities.
    Kellner LH; Weiss RR; Weiner Z; Neuer M; Martin GM; Schulman H; Lipper S
    Am J Obstet Gynecol; 1995 Mar; 172(3):831-6. PubMed ID: 7534448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
    Palomaki GE; Knight GJ; Haddow JE; Canick JA; Saller DN; Panizza DS
    Prenat Diagn; 1992 Nov; 12(11):925-30. PubMed ID: 1283634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.
    Duric K; Skrablin S; Lesin J; Kalafatic D; Kuvacic I; Suchanek E
    Eur J Obstet Gynecol Reprod Biol; 2003 Sep; 110(1):12-5. PubMed ID: 12932863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low maternal serum human chorionic gonadotrophin and unconjugated oestriol in a triploidy pregnancy.
    Mason G; Linton G; Cuckle H; Holding S
    Prenat Diagn; 1992 Jun; 12(6):545-7. PubMed ID: 1513759
    [No Abstract]   [Full Text] [Related]  

  • 13. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum analyte levels after first-trimester multifetal pregnancy reduction.
    Shulman LP; Phillips OP; Cervetti TA
    Am J Obstet Gynecol; 1996 Mar; 174(3):1072-4. PubMed ID: 8633639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
    Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A
    Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome.
    Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA
    Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
    Rose NC; Mennuti MT
    West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An artificial intelligent diagnostic system with neural networks to determine genetical disorders and fetal health by using maternal serum markers.
    Beksaç MS; Durak B; Ozkan O; Cakar AN; Balci S; Karakaş U; Laleli Y
    Eur J Obstet Gynecol Reprod Biol; 1995 Apr; 59(2):131-6. PubMed ID: 7544745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.